US5573934A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Gels for encapsulation of biological materials
Assignee: The University of Texas System
•
Filing: 1993-03-01
•
Granted: 1996-11-12
•
Expires: 2013-03-01
Abstract
Abstract Water soluble macromers are modified by addition of free radical polymerizable groups, such as those containing a carbon-carbon double or triple bond, which can be polymerized under mild conditions to encapsulate tissues, cells, or biologically active materials. The polymeric materials are particularly useful as tissue adhesives, coatings for tissue lumens including blood vessels, coatings for cells such as islets of Langerhans, coatings, plugs, supports or substrates for contact with biological materials such as the body, and as drug delivery devices for biologically active molecules.
Inventors
- 👤 Jeffrey A. Hubbell
- 👤 Chandrashekhar P. Pathak
- 👤 Amarpreet S. Sawhney
- 👤 Neil P. Desai
- 👤 Jennifer L. Hill-West
- 👤 Syed F. A. Hossainy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:10
CPC Classifications
C; C12; C12N; C12N11/00; C12N11/02; C12N11/04; A; A61; A61K; A61K38/00; A61K38/16; A61K38/41; A61K38/42; A61K38/43; A61K38/44; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/64; A61K47/645; A61K47/69; A61K47/6903; A61K47/6921; A61K47/6927; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; A61K9/1641; A61K9/1647; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5026; A61K9/5031; A61K9/5073; A61L; A61L24/00; A61L24/001; A61L24/0031; A61L24/0042; A61L24/04; A61L24/046; A61L26/00; A61L26/0009; A61L26/0019; A61L27/00; A61L27/28; A61L27/34; A61L27/36; A61L27/3683; A61L27/38; A61L27/50; A61L27/52; A61L29/00; A61L29/08; A61L29/085; A61L31/00; A61L31/08; A61L31/10; A61L31/14; A61L31/145; A61L31/148; B; B82; B82Y; B82Y5/00; C08; C08B; C08B37/00; C08B37/0006; C08B37/0024; C08B37/0027; C08B37/003; C08B37/006; C08B37/0063; C08B37/0072; C08B37/0084; C08F; C08F290/00; C08F290/02; C08F290/06; C08F290/062; C08F290/08; C08F290/10; C08F291/00; C09; C09D; C09D153/00; C12N5/00; C12N5/0012; C12N5/06; C12N5/0602; C12N5/0676; C12N5/0677; A61K35/00; A61K35/12; A61K2035/126; A61K2035/128; C12N2533/00; C12N2533/30; C12N2533/32; C12N2533/40; C12N2533/70; C12N2533/74; Y; Y10; Y10S; Y10S530/00; Y10S530/81; Y10S530/812; Y10S530/813; Y10S530/815; Y10S530/817; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984; Y10T428/2985; Y10T428/2987; Y10T428/2989
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
144 words
A method for encapsulating, sealing, coating or supporting a biological material comprising: a) contacting a solution of a non-toxic free radical polymerization initiator selected from the group consisting of visible or long wavelength ultraviolet light-activatable free radical initiators, thermal activatable free-radical initiators with a biological material selected from the group consisting of mammalian cells, components of mammalian cells, aggregates of mammalian cells, and mammalian tissues, to allow binding of the initiator to the biological material; b) removing the unbound initiator; c) adding to the biological material a water soluble biocompatible macromer comprising at least two free radical polymerizable end groups, wherein the macromer is non-toxic and has a molecular weight of at least 400, and d) exposing the mixture to an agent activating the initator to cause polymerization of the macromers to form a polymeric gel with a degree of polymerization greater than 10.
Claim 2
Independent Claim
144 words
A method for encapsulating, sealing, coating or supporting a biological material comprising: a) contacting a solution of a non-toxic free radical polymerization initiator selected from the group consisting of visible or long wavelength ultraviolet light-activatable free radical initiators, thermal activatable free-radical initiators with a biological material selected from the group consisting of mammalian cells, components of mammalian cells, aggregates of mammalian cells, and mammalian tissues, to allow binding of the initiator to the biological material; b) removing the unbound initiator; c) adding to the biological material a water soluble biocompatible macromer comprising at least two free radical polymerizable end groups, wherein the macromer is non-toxic and has a molecular weight of at least 400, and d) exposing the mixture to an agent activating the initator to cause polymerization of the macromers to form a polymeric gel with a degree of polymerization greater than 10.
Claim 3
Dependent Claim
46 words
The method of claim 1 further comprising adding to the biocompatible macromer a biologically active molecule selected from the group consisting of peptides of less than one hundred amino acids, proteins of one hundred or more amino acids, polysaccharides, nucleic acids, organic drugs, and inorganic drugs.
Claim 4
Dependent Claim
16 words
The method of claim 1 wherein the free-radical polymerizable endgroups contain carbon-carbon double or triple bonds.
Claim 5
Dependent Claim
42 words
The method of claim 1 wherein the water soluble macromer is selected from the group consisting of poly(ethylene glycol), poly(ethylene oxide), poly(vinyl alcohol), poly(vinylpyrrolidone), poly(ethyloxazoline), poly(amino acid), polysaccharides, proteins, or a block or random copolymer thereof comprising two or more polymerizable substituents.
Claim 6
Dependent Claim
37 words
The method of claim 4 wherein the polysaccharide is selected from the group consisting of alginate, hyaluronic acid, chondroitin sulfate, dextran, dextran sulfate, heparin, heparin sulfate, heparan sulfate, chitosan, gellan gum, xanthan gum, guar gum, and K-carrageenan.
Claim 7
Dependent Claim
19 words
The method of claim 4 wherein the protein is selected from the group consisting of gelatin, collagen and albumin.
Claim 8
Dependent Claim
23 words
The method of claim 1 wherein the free-radical polymerizable endgroups are selected from the group of macromers containing two or more acrylate groups.
Claim 9
Dependent Claim
18 words
The method of claim 1 wherein the polymer is prepared from macromers comprising an acrylate terminated poly(ethylene glycol).
Claim 10
Dependent Claim
41 words
The method of claim 1 wherein the polymerization initiator is selected from the group consisting of an eosin dye, riboflavin, acetophenone, a substituted acetophenone, a fluorescein dye camphorquinone, rose bengal, methylene green, methylene blue, acridine orange, xanthine dye, and thioxanthine dyes.
Claim 11
Dependent Claim
20 words
The method of claim 1 wherein the polymerization initiator is selected from the group consisting of erythrosin, phloxine, and thionine.
Claim 12
Dependent Claim
20 words
The method of claim 1 wherein polymerization is initiated by visible light having a wavelength of less than 800 nm.
Claim 13
Dependent Claim
14 words
The method of claim 11 wherein the light has a wavelength of 514 nm.
Claim 14
Dependent Claim
35 words
The method of claim 1 wherein the unbound initiator is removed by dilution with the macromer solution such that polymerization occurs only at the surface of the mammalian cell, mammalian cell aggregate, or mammalian tissue.
Claim 15
Dependent Claim
20 words
The method of claim 1 wherein polymerization of the macromer solution adheres mammalian tissue to other mammalian tissue or cells.
Claim 16
Dependent Claim
56 words
The method of claim 1 wherein the initiator is a photoinitiator which is activated by exposure to visible light, and the water soluble macromer is selected from the group consisting of poly(alkylene glycol), poly(alkylene oxide), poly(vinyl alcohol), poly(vinylpyrrolidone), poly(ethyloxazoline), poly(amino acid), polysaccharides, proteins, or a block or random copolymer thereof comprising two or more polymerizable substituents.
Claim 17
Dependent Claim
21 words
The method of claim 15 wherein the macromer is poly(ethylene glycol) and the free radical polymerizable groups contain carbon-carbon double bonds.
References Cited (Backward Citations)
US4450150A
Cited
US4321117A
Cited
US4411754A
Cited
US4329332A
Cited
US4295762A
Cited
US4298002A
Cited
US4359483A
Cited
US4376059A
Cited
US4590068A
Cited
US4434150A
Cited
US4647536A
Cited
US4526938A
Cited
US4942035A
Cited
US4652443A
Cited
US4511478A
Cited
US4605622A
Cited
US4563489A
Cited
US4774178A
Cited
US4745160A
Cited
US4637931A
Cited
EP0195304A2
Cited
US4950596A
Cited
US4822535A
Cited
US4931279A
Cited
US4889722A
Cited
US5160745A
Cited
US4957744A
Cited
US5037656A
Cited
US4913903A
Cited
US5288500A
Cited
US4826945A
Cited
US4804691A
Cited
US4916193A
Cited
US5185408A
Cited
US4888413A
Cited
US5268182A
Cited
US4925677A
Cited
US4938763A
Cited
US4938763B1
Cited
US5278201A
Cited
US5278202A
Cited
US5271961A
Cited
WO1991010425A1
Cited
US5183690A
Cited
US5219564A
Cited
US5149543A
Cited
US5153002A
Cited
WO1993009176A2
Cited
WO1993017669A1
Cited
WO1993021266A1
Cited
US5334640A
Cited
US5286495A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-11-12 | 2000-05-13 | 2000-11-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-11-12 | 2004-05-13 | 2004-11-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-11-12 | 2008-05-13 | 2008-11-12 | $7700.00 | Window Closed / Lapsed |